ニューヨークにおける腎臓がんの臨床試験
ニューヨーク内の拠点で、腎臓がんに関する17件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06234605Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
- Roswell Park Comprehensive, Buffalo
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05287945Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Research Site, Buffalo
- Research Site, New York
- Research Site, Rochester
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07011719Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- NYU Langone Medical Center, New York
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT04981119Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- New York Oncology Hematology, P.C., Albany
- New York Oncology Hematology - Clifton Park Cancer Center, Clifton Park
- MSK Commack, Commack
- 他7件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07227415A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- Research Site, New York
- Research Site, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/31更新 · NCT05536141A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/11更新 · NCT07195682Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
- NEO-811 Long Island Site, Lake Success
- NEO-811 NYC Site, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/03更新 · NCT07300241Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, New York
- Xencor Investigative Site, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/03更新 · NCT05433142A Study of a Side Effects and Resource Navigation Program for People With Cancer
- Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- City College of New York (Data Collection AND Specimen Analysis), New York
- 他2件
被験者募集中
18歳以上 · 全性別 · 2026/07/31更新 · NCT07646847Integrated Cancer Repository for Cancer Research
- C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
- Faxton St. Luke's Healthcare, Mohawk Valley, Utica
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Brodalumab in the Treatment of Immune-Related Adverse Events
- Columbia University Irving Medical Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/05/13更新 · NCT06673329Kidney Cancer DNA Registry
- Memorial Sloan Kettering Commack (Consent and Follow-up), Commack
- Memorial Sloan Kettering Westchester (Consent and Follow up), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 他1件
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/04/09更新 · NCT02087852Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- 他1件
被験者募集中観察研究健康なボランティア歓迎
全年齢 · 全性別 · 2026/01/23更新 · NCT00582621Decision Aid (DA) for Renal Patients
- NYU Langone Health, New York
被験者募集中
18歳以上 · 全性別 · 2025/12/02更新 · NCT05387863SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- 他2件
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- NYU Langone Health, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/09/09更新 · NCT06682793ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。